ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚Ì­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > •½¬25”N“x@Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘ÎôŒ¤‹†Ž–‹Æ

ƒGƒCƒY‘ÎôŒ¤‹†Ž–‹Æ

i›FˆÏˆõ’·j

 
’rã@çŽõŽq “Á’è”ñ‰c—˜Šˆ“®–@l‚Õ‚ê‚¢‚·“Œ‹ž—Ž–
ƒZƒNƒ\ƒƒW[
uŽv‚¢‚±‚Ý‚Ì«AƒŠƒXƒL[‚ȃZƒbƒNƒXv’rãçŽõŽq’˜AŠâ”g‘“XA2011
u21¢‹I‚̉ۑ衂±‚»AƒGƒCƒY‚ðl‚¦‚év’rãçŽõŽq’˜@à’c–@l“ú–{«‹³ˆç‹¦‰ï@«‹³ˆçƒnƒ“ƒhƒuƒbƒNvol.5 2011
uƒGƒCƒYESTD‚Æ«‚Ì‹³ˆçv’rãçŽõŽq‘¼‹¤’˜@\ŒŽŽÉ@2002
 
¡‘º@’m–¾ “Þ—ÇŒ§—§ˆã‰È‘åŠwE‹³Žö
ŒöO‰q¶ŠwAŒ’N­ôˆãŠwAˆã—íô
‚`‚h‚c‚r^Š´õŽÒV‹K•ñ”ä—¦|‚¢‚í‚ä‚éu‚¢‚«‚È‚è‚`‚h‚c‚r—¦v|‚ÌŒŸ“¢. ¬ìr•vA”’â‘ô–A¡‘º’m–¾. “ú–{ƒGƒCƒYŠw‰ïŽ. 2012 Feb;14(1):46-54.
‚g‚h‚uf—ÂɊւí‚錴‰¿‚ÌŽÀ‘Ô’²¸. ˆäo”Ž¶AÔ‰HŠwA”’ã‘ô–A¡‘º’m–¾. “ú–{ƒGƒCƒYŠw‰ïŽ. 2010 Feb;12(1):49-55.
History of public health crises in Japan. Imamura T, Ide H, Yasunaga H. J Public Health Policy. 2007 Nov;28(2):221-237
 
Šâ–{@ˆ¤‹g “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†ŠE‹³Žö
Š´õÇŠwEƒEƒCƒ‹ƒXŠw
Kikuchi, T., Iwatsuki-Horimoto, K., Adachi, A., Koga, M., Nakamura, H., Hosoya, N., Kawana-Tachikawa, A., Koibuchi, T., Miura, T., Fujii, T., Kawaoka, Y., and Iwamoto, A. Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults. Vaccine 30: 3819-3823, 2012. EPub April 10, 2012.
Kondo, N., Miyauchi, K. Meng, F. Iwamoto, A. and Matsuda, Z. Conformational changes of the HIV-1 envelope protein during membrane fusion were inhibited by the replacement of its membrane-spanning domain. J. Biol. Chem. 285:14681-14688, 2010. May 7, 2010.
Miyazaki, E., Kawana-Tachikawa, A., Tomizawa, M., Nunoya, J., Odawara, T., Fujii, T., Shi, Y., Gao, G.F., and Iwamoto, A. Highly restricted TCR repertoire in the CD8-positive T cell response against an HIV-1 epitope with a stereotypic amino acid substitution. AIDS 23:651-660, 2009.
 
¬–쎛@ºˆê •xŽmŽs—§’†‰›•a‰@E‰@’·A“Œ‹žŽœŒb‰ïˆã‰È‘åŠw‹qˆõ‹³Žö
”å”AŠí‰ÈA”A˜HE«ŠíŠ´õÇAŠ´õ§Œä
Comparison of free and anonymous testing for HIV and sexually@transmitted infections between the University Hospital and Health@Center. Yoshida M, Chiba A, Kawano S, Kato T, Sato F, Horino T, Nakazawa Y, Yoshikawa K, Onodera S, Hori S. J Infect Chemother. 2012 Mar 23.[Epub ahead of print]
HIVŠ´õŽÒ‚Ì”~“Å‚ÉŠÖ‚·‚錟“¢.²“¡•¶Æ,‰Í–ì^“ñ,‰Á“¡“N˜N,–x–ì“N–ç,’†àV –õ,‹gìWŽi,‹g“c³Ž÷,¬–쎛ºˆê.“ú«Š´õljïŽ20i1jF2009F192-197.
¬–쎛ºˆêFŒú¶˜J“­‰ÈŠwŒ¤‹†•â•‹à VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU“™V‹»EÄ‹»Š´õÇŒ¤‹†Ž–‹Æu«Š´õÇ‚ÉŠÖ‚·‚é—\–hAŽ¡—Â̑̌n‰»‚ÉŠÖ‚·‚錤‹†viŒ¤‹†‘ã•\ŽÒF¬–쎛ºˆêj•½¬21”N“x`•½¬23”N“x‘‡Œ¤‹†•ñ‘
‘q“c@‹B ‘Ûˆã—ÕŸŽƒ‘åŠw‰–’J•a‰@
ƒEƒCƒ‹ƒXŠ´õÇ
Intranasal administration ofadjyvant-combined vaccine protects Monkeys from challenge with the highly pathogenic infkuenza A H5N1 Virus. Ichinihe T. Ainai A. Ami Y Nagata N.Iwata N.Kawaguchi A. Suzuki Y. Odagiri T.Tashiro M.Takahashi H. Strayer DR.Carter WA.Chia j.Tamura S. Sata T. Kurata T. Hasegawa H. J.Med.Virol.2010.82:1754-1761.
Continuity and change of Japanese encephalitis virus in Toyama pre-Fecture.Japan. Obara M. Yamauchi T. Watanabe M. Hasegawa S. UedaY. Matsuno K. Iwai M. Horimoto E. Kurata T. Takizawa T. Kariwa H. Takashima I. American J. Trop. Med. & Hygiene 2011. 84:695-708
Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated infkuennza vacnine.
Ainai A. Tamura S. Suzuki T. Ito R. Asanuma H.,Tanimoto T.Gomi Manabe S. Ishikawa T.Okuno Y. Odagiri T. Tashiro M.Sata T.Kurata T. And Hasegawa H. J. Med. Virol.2012. 84.336-344
 
‘ŠŠy@—TŽq Š‘®‚È‚µ
—Õ°Š´õÇŠw
“ˆ‹MŽqC{“¡O“ñC‹ß“¡^‹KŽqC‘qˆä‰ØŽqC‘ŠŠy—TŽqC¡ˆäŒõMFŒuŒõy‘f–Ɖu‘ª’è–@‚É‚æ‚éV‚µ‚¢HIVRŒ´R‘Ì“¯ŽžŒŸoŽŽ–òi‘æ4¢‘ãj‚ÌŒŸ“¢DŠ´õÇŠw‰ïŽ81F562-572C2007
’ËŒ´—DŒÈC‘ŠŠy—TŽqCŠì‘½P˜aC“ˆ‹MŽqC–î‰i—R—ŽqCŠO쳶C‘å‹à”ü˜aCˆî—tŒ›”VF‘æ20‰ñ“ú–{ƒGƒCƒYŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€ Š´õ—«‚Ì”DPEoŽYEˆçŽ™Žx‰‡D“ú–{ƒGƒCƒYŠw‰ïŽ9F116-119C2007D
Mohri S, Yoshikawa K, Sagara H, Nakajima, HFA case of Penicillium marneffei infection in an AIDS patient -the first case in Japan-. Jpn J
Med Mycol 41: 23-26, 2000.
 
‹{“c@ˆê—Y ƒGƒCƒY—\–hà’c—Ž–
Š´õÇŠwEŒŒ‰t“à‰ÈŠw
w¢ŠE‚̓GƒCƒY‚Æ‚Ç‚¤“¬‚Á‚Ä‚«‚½‚Ì‚©x ‹{“cˆê—Y ƒ|ƒbƒgo”Å 2002”N
‘æ24‰ñ“ú–{ƒGƒCƒYŠw‰ïƒjƒ…[ƒYƒŒƒ^[1`7i•Ò’˜j@‹{“cˆê—YE‰iˆÕŽŠ•¶ 2010”N4ŒŽ`12ŒŽ
wVƒGƒCƒY—\–hŽwj‚ÆŽ„‚½‚¿xi•Ò’˜j ƒGƒCƒY—\–hà’c•Òi‹{“cˆê—YE‰iˆÕŽŠ•¶j ˜A‡o”Å 2012”N

ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚Ì­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > •½¬25”N“x@Œú¶˜J“­‰ÈŠwŒ¤‹†”ï•â•‹à‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘ÎôŒ¤‹†Ž–‹Æ

ƒy[ƒW‚Ì擪‚Ö–ß‚é